Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WHO panel: Use of unproven Ebola treatments ethical

This article was originally published in Scrip

Executive Summary

A special panel of medical ethicists and other experts convened by the World Health Organization (WHO) said it is ethical to offer unproven experimental interventions with unknown efficacy and adverse effects as potential treatments for or preventions against Ebola – a disease which has now killed more than 1,000 people in Guinea, Liberia, Nigeria, and Sierra Leone, with the international agency reporting 1,848 cases in the largest, most severe outbreak in history.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts